Global /China /Healthcare /Biotechnology /6887

Sunshine Lake Pharma Co., Ltd.

6887

• SHEK: 6887 • Delayed

41.20HKD -1.3%

5.26 USD

As of 14 June 2026, Sunshine Lake Pharma Co., Ltd. has a market cap of $3.07B USD, ranking #5341 globally and #1143 in China. It ranks #415 in the Healthcare sector, and #73 in the Biotechnology industry.

Global Rank

5341

Country Rank

1143

Sector Rank

415

Industry Rank

Key Stats

Market Cap

$3.07BUSD

24.04B HKD

Enterprise Value

$3.52BUSD

27.57B HKD

Revenue (TTM)

$683.69MUSD

5.36B HKD

EBITDA (TTM)

$152.62MUSD

1.2B HKD

Net Income (TTM)

$38.68MUSD

303.18M HKD

EBITDA Margin

22%

Profit Margin

5.7%

PE Ratio

68.2

PS Ratio

4.5

PB Ratio

5.0

EV/EBITDA

23.1

Company Profile

Country (HQ)

China

Sector

Healthcare

Industry

Biotechnology

CEO

Wenjia Li open_in_new

Employees

6,533

Founded

2001

Website

hecpharm.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-1.3%	-1.8%	-3.5%	-9.4%	-10%	-8.3%	-9.8%	56%	31%

News

Markets

Exchange	Ticker	Price	Quotes
Hong Kong Stock Exchange (SHEK / HKEX) MIC: XHKG PRIMARY	6887 ISIN: CNE1000070M8 Shares Out.: Shares Outstanding: 321.103M¹ Shares Float: 162.251M² TV: TradingView: HKEX: 6887 SA: Stock Analysis: HKG: 6887 YF: Yahoo Finance: 6887.HK GF: Google Finance: HKG: 6887 BA: Barron's: 6887 MS: Morningstar: XHKG: 06887	41.20 HKD	TV: TradingView: HKEX: 6887 SA: Stock Analysis: HKG: 6887 YF: Yahoo Finance: 6887.HK GF: Google Finance: HKG: 6887 BA: Barron's: 6887 MS: Morningstar: XHKG: 06887

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Sunshine Lake Pharma Co., Ltd.

Sunshine Lake Pharma Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical products for the treatment of infectious diseases, chronic diseases, and oncology. It offers Kewei for the treatment of influenza; Dongweien for the treatment of hepatitis C; and generic drugs for the treatment of infections caused by sensitive bacteria, namely Clarithromycin, Levofloxacin, and Moxifloxacin Hydrochlorid, as well as active pharmaceutical ingredients. The company also engages in the wholesale, retail, import, and export of drugs. The company was formerly known as Sunshine Lake Pharma Ltd. The company was incorporated in 2001 and is based in Dongguan, China.

Similar Companies

Industry: Biotechnology (China)

Name	Market Cap (USD) diff.	PE	Country
WuXi Biologics (Cayman) Inc. SHEK: 2269	$17.44B 136.71B HKD 469%	25.3	China
CSPC Pharmaceutical Group Ltd. SHEK: 1093	$12.2B 95.58B HKD 298%	22.1	China
Sichuan Kelun Pharmaceutical Co., Ltd. SHE: 002422	$8.0B 54.23B CNY 161%	34.4	China
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. SSE: 603392	$7.33B 49.69B CNY 139%	-	China
3SBio Inc. SHEK: 1530	$7.08B 55.5B HKD 131%	5.8	China
Hangzhou Tigermed Consulting Co., Ltd. SHE: 300347	$6.72B 45.52B CNY 119%	61.6	China

Industry: Biotechnology (Global)

Name	Market Cap (USD) diff.	PE	Country
Amgen Inc. NASDAQ: AMGN	$182.42B 6K%	23.9	United States
Gilead Sciences, Inc. NASDAQ: GILD	$159.92B 5K%	19.0	United States
argenx SE EBR: ARGX	$47.84B 41.39B EUR 1K%	39.9	Netherlands
Samsung Biologics Co.,Ltd. KRX: 207940	$44.84B 68.19T KRW 1K%	35.5	South Korea
CSL Ltd. ASX: CSL	$42.36B 60.27B AUD 1K%	29.3	Australia
Lonza Group AG SIX: LONN	$42.3B 33.71B CHF 1K%	37.2	Switzerland

chevron_leftBack